The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Open accessAbstract
BACKGROUND: In previous clinical trials involving children with X-linked severe combined immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based γ-retrovirus vector expressing interleukin-2 receptor γ-chain (γc) complementary DNA successfully restored immunity in most patients but resulted in vector-induced leukemia through enhancer-mediated mutagenesis in 25% of patients. We assessed the efficacy and safety of a self-inactivating retrovirus for the treatment of SCID-X1. METHODS: We enrolled nine boys with SCID-X1 in parallel trials in Europe and the United States to evaluate treatment with a self-inactivating (SIN) γ-retrovirus vector containing deletions in viral enhancer sequences expressing γc (SIN-γc). RESULTS: All patients received bone marrow-derived CD34+ cells transduced with the SIN-γc vector, without preparative conditioning. After 12.1 to 38.7 months of follow-up, eight of the nine children were still alive. One patient died from an overwhelming adenoviral infection before reconstitution with genetically modified T cells. Of the remaining eight patients, seven had recovery of peripheral-blood T cells that were functional and led to resolution of infections. The patients remained healthy thereafter. The kinetics of CD3+ T-cell recovery was not significantly different from that observed in previous trials. Assessment of insertion sites in peripheral blood from patients in the current trial as compared with those in previous trials revealed significantly less clustering of insertion sites within LMO2, MECOM, and other lymphoid proto-oncogenes in our patients. CONCLUSIONS: This modified γ-retrovirus vector was found to retain efficacy in the treatment of SCID-X1. The long-term effect of this therapy on leukemogenesis remains unknown. (Funded by the National Institutes of Health and others; ClinicalTrials.gov numbers, NCT01410019, NCT01175239, and NCT01129544.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Self-citationGene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,703
Self-citationAkaike's Information Criterion in Generalized Estimating Equations
Pan, W. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00120.x · Cited by 2,545
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Self-citationGeneralized Estimating Equations
Hardin, J. W., & Hilbe, J. M. (2002) · doi:10.1201/9781420035285 · Cited by 1,766
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,338
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Self-citation
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Gaspar HB, 2011, Sci Transl Med, 3, 97ra79
- Coffin JM, Hughes SH, Varmus HE. Retroviruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1997.
Cited by
Sorted by citations
Items 401–411 of 411
RNA Viruses and Vaccine Development
Lundstrom, K. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_8
Rimbert, M., AUDRAIN, M. A. P., Léger, A., Miot, C., Fantou, A., Hémont, C., Lemoine, L., Poli, C., Pellier, I., Catteau, A., et al. (2025) · Archives de Pédiatrie · doi:10.1016/j.arcped.2025.07.004
Gene Therapy for Inborn Errors of Immunity
Caetano-Silva, S. P., & Booth, C. (2025) · Wiley eBooks · doi:10.1002/9780470015902.a0029694
Gene therapy approach on Charcot-Marie-Tooth type 1A rats
Hajjar, H. (2018) · theses.fr (ABES) · doi:10.70675/014f2329za7dbz40a5z9c75z92e60af2b4a0
Preclinical development of a T cell based gene therapy to treat IPEX syndrom
Delville, M. (2019) · theses.fr (ABES) · doi:10.70675/a98fdc5dz0036z4620z848ez66c60ea7bd96
Verdera, H. C. (2019) · theses.fr (ABES) · doi:10.70675/3d2d8524z211ez4408zbdfbz56c065f452a1
Ex vivo gene therapy for β-hemoglobinpathies and metabolic disorders
Laurent, M. (2023) · theses.fr (ABES) · doi:10.70675/ba5c585dzaa79z48d2z9f40zfee1cdd49d32
Trajectoires clonales de l’hématopoïèse post-greffe
Guyonneau-Harmand, L., & Jaffredo, T. (2026) · médecine/sciences · doi:10.1051/medsci/2026056
Primary Immunodeficiency Disorders
Gennery, A. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-13858-3_50
Gene therapy approaches for inborn errors of immunity: from bench to bedside
Dara, J., & Booth, C. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2710870
Metadata
- Authors
- Hacein-Bey-Abina, S., Pai, S.-Y., Gaspar, H. B., Armant, M., Berry, C. C., Blanche, S., Bleesing, J., Blondeau, J., de Boer, H., Buckland, K. F., Caccavelli, L., Cros, G., De Oliveira, S., Fernández, K. S., Guo, D., Harris, C. E., Hopkins, G., Lehmann, L. E., Lim, A., London, W. B., van der Loo, J. C. M., Malani, N., Male, F., Malik, P., Marinovic, M. A., McNicol, A.-M., Moshous, D., Neven, B., Oleastro, M., Picard, C., Ritz, J., Rivat, C., Schambach, A., Shaw, K. L., Sherman, E. A., Silberstein, L. E., Six, E., Touzot, F., Tsytsykova, A., Xu-Bayford, J., Baum, C., Bushman, F. D., Fischer, A., Kohn, D. B., Filipovich, A. H., Notarangelo, L. D., Cavazzana, M., Williams, D. A., & Thrasher, A. J.
- Affiliations
- Boston Children's Hospital (US)
- Great Ormond Street Hospital (GB)
- Cincinnati Children's Hospital Medical Center (US)
- Inserm (FR)
- University College London (GB)
- Peoria campus of the University of Illinois System (US)
- Institut Pasteur (FR)
- University of Pennsylvania (US)
- Clinica Santa Maria (CL)
- Sorbonne Paris Cité (FR)
- Garrahan Hospital (AR)
- Medizinische Hochschule Hannover (DE)
- University of California, Los Angeles (US)
- Harvard University (US)
- ORCID
- Pai, Sung-Yun
- Gaspar, H. Bobby
- Armant, Myriam
- Bleesing, Jack
- Buckland, Karen F.
- Caccavelli, Laure
- Cros, Guilhem
- Fernández, Karen S.
- Harris, Chad E.
- Lehmann, Leslie E.
- London, Wendy B.
- Malani, Nirav
- Malik, Punam
- Moshous, Despina
- Ritz, Jerome
- Schambach, Axel
- Shaw, Kit L.
- Sherman, Eric A.
- Silberstein, Leslie E.
- Six, Emmanuelle
- Touzot, Fabien
- Tsytsykova, Alla
- Bushman, Frederic D.
- Fischer, Alain
- Kohn, Donald B.
- Notarangelo, Luigi D.
- Cavazzana, Marina
- Williams, David A.
- Thrasher, Adrian J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-10-09
- Volume
- 371
- Issue
- 15
- Pages
- 1407-1417
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4274995
- OpenAlex
- W2149628283
- Cited by
- 412
- References
- 46
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 17 · 2023: 26 · 2022: 30 · 2021: 17 · 2020: 42 · 2019: 48 · 2018: 36 · 2017: 57 · 2016: 46 · 2015: 56 · 2014: 4
- FWCI
- 35.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NF-SI-0611-10001)
- National Heart, Lung, and Blood Institute (P01HL073104, HL073104, HHSN268201000009C)
- National Institute of Allergy and Infectious Diseases (U01AI087628, R01AI082020, P30AI045008, AI082020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- X-linked severe combined immunodeficiency, interleukin-2 receptor gamma chain, LMO2, MECOM, gene therapy, CD34+ hematopoietic stem cells, T cell reconstitution, adenovirus infection
- MeSH terms
- Animals, Genetic Vectors, Humans, Infant, Male, Mutation, T-Lymphocytes, Transduction, Genetic, Genetic Therapy, Gene Expression, Gammaretrovirus, DNA, Complementary, Antigens, CD34, Transgenes, Gene Silencing, Mice, Interleukin Receptor Common gamma Subunit, X-Linked Combined Immunodeficiency Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
